Page last updated: 2024-10-22

theophylline and Neuroleptic Malignant Syndrome

theophylline has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misawa, D1
Ohshima, K1
Watanabe, M1
Asai, K1
Ino, T1
Ueda, M1

Other Studies

1 other study available for theophylline and Neuroleptic Malignant Syndrome

ArticleYear
[Rhabdomyolysis: case report of 11 patients].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Jul-10, Volume: 94, Issue:7

    Topics: Adult; Aged; Enteritis; Female; Humans; Hypokinesia; Influenza A virus; Influenza, Human; Male; Midd

2005